BioSpace.com News

Lightlake Therapeutics Inc.??? Binge Eating Disorder Treatment Phase II Trial Results Presented at American Psychiatric Association 2013 Annual Meeting

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LONDON--(BUSINESS WIRE)--Lightlake Therapeutics Inc. (OTCBB: LLTP) (the Company, We or Lightlake), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists...

Galena Biopharma to Present at the Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LAKE OSWEGO, Ore., May 23, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance...

Amyris, Inc. to Participate at the Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

EMERYVILLE, Calif., May 22, 2013 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leading renewable chemicals and fuels company, announced today that the Company will participate in a renewable biomaterials...

Prometheus Laboratories Inc. Presents New Data On Growing IBD Diagnostic Portfolio at

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO, May 22, 2013 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company...

Amgen Announces Voting Results of Annual Meeting of Stockholders

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

THOUSAND OAKS, Calif., May 22, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced voting results from...

Heska Corporation to Present at the

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LOVELAND, Colo., May 22, 2013 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading...

Inhibikase Therapeutics to Present at

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ATLANTA, May 23, 2013 /PRNewswire/ -- Inhibikase Therapeutics, Inc., an emerging leaderin infectious disease...

BioLife Solutions, Inc. Announces Presentation at

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOTHELL, Wash., May 23, 2013 /PRNewswire/ -- BioLife Solutions...

Verenium Corporation to Present at Two Upcoming Conferences

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO, May 23, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company...

DiaGenic ASA: Annual General Meeting Held

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

The annual general meeting of DiaGenic ASA (OSE:DIAG) was held on 23 May 2013.

All proposals set out in the notice to the general meeting were approved.

In...

Ligand Pharmaceuticals Inc. to Present at Upcoming Investor Conferences

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that Ligand management is scheduled to present at the following upcoming investor conferences:

Deutsche Bank 38th Annual dbAccess...

Dyax Corp. Announces Participation in Upcoming Investor Events

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Dyax Corp. (NASDAQ: DYAX) announced today its participation in the following investor events:

Deutsche Bank 38th Annual db Access Health Care Conference on Wednesday, May 29 in Boston, Massachusetts...

Lightlake Therapeutics Inc.??? Binge Eating Disorder Treatment Phase II Trial Results Presented at American Psychiatric Association 2013 Annual Meeting

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Lightlake Therapeutics Inc. (OTCBB: LLTP) (the Company, We or Lightlake), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that...

Baxter International, Inc. to Present at the Goldman, Sachs & Co. 34th Annual Global Healthcare Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Baxter International Inc. (NYSE: BAX) announced today that it will present at the Goldman Sachs 34th Annual Global Healthcare Conference on Tuesday, June 11, 2013 at 4:40 p.m. (CT).

The live webcast...

Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders -- New Phone Number for Audio Portion of Presentation

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ATLANTA, May 23, 2013/PRNewswire/ -- Galectin...

Organogenesis Inc. Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CANTON, Mass. and NEW ORLEANS, May 22, 2013 /PRNewswire/ -- Organogenesis...

Synageva BioPharma to Present at the Jefferies and Co. 2013 Global Healthcare Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, today announced that Sanj K. Patel, President and Chief Executive Officer...

Cambrex Corporation to Present at Jefferies and Co. 2013 Global Healthcare Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

EAST RUTHERFORD, N.J., May 23, 2013 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce...

PAREXEL International to Present at Jefferies and Co. Healthcare Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOSTON, May 23, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be...

Konan Medical USA Inc. Release: Six Month Data Reported for WAVE I Study of Renal Denervation Therapy for Hypertension at Meeting in Paris

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Kona Medical announced that three and six month results from the WAVE I study were presented today at the late-breaking clinical trials session of EuroPCR in Paris by Robert Whitbourn, MD, of St. Vincents Hospital...

Pharmagen to Present at the Second Annual Marcum LLP MicroCap Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SILVER SPRING, Md., May 23, 2013 /PRNewswire/ -- Pharmagen, Inc. (OTCBB: PHRX) (the "Company" or "Pharmagen") announced...

Cancer Genetics, Inc. to Present at MicroCap Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Cancer Genetics, Inc. (OTCQB: CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based cancer diagnostics, will present at the second annual Marcum MicroCap Conference on Thursday, May 30, 2013 at 2...

Targeted Medical Pharma to Present at MicroCap Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Targeted Medical Pharma, Inc. (OTCBB: TRGM), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced that its Chief Executive and Chief...

CEL-SCI to Present at the Second Annual MicroCap Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VIENNA, Va., May 23, 2013 /PRNewswire/ -- CEL-SCI Corporation (NYSE MKT: CVM) announced today that

Northwest Biotherapeutics Exhibit at the Upcoming American Society of Clinical Oncology Meeting to Highlight its Leadership Role in Immune Therapy for Cancer

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BETHESDA, Md., May 23, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company...

AEterna Zentaris: Posters to be Presented on Phase 1 and Phase 2 Trials with AEZS-108 in Prostate and Breast Cancer at Upcoming American Society of Clinical Oncology Meeting

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

QUBEC CITY, May 23, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the following...

Verastem, Inc. to Present at the 2013 American Society of Clinical Oncology Annual Meeting

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Verastem, Inc., (NASDAQ: VSTM) focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that members of the research and development team will present...

Tesaro, Inc. to Present at the Deutsche Bank 38th Annual 2013 Health Care Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WALTHAM, Mass., May 22, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, Chief Executive Officer, and Mary Lynne Hedley, Ph.D., President, will present at the Deutsche...

Isis Pharmaceuticals, Inc. to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CARLSBAD, Calif., May 23, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics...

Spectrum Pharmaceuticals, Inc. to Present Corporate Update at the Deutsche Bank 38th Annual Health Care Conference in Boston on May 30th

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview...

Ariad Pharmaceuticals, Inc. to Present at the Deutsche Bank 38th Annual Healthcare Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Deutsche Bank 38th Annual Healthcare Conference being held in Boston. Harvey J. Berger, M.D., chairman and chief executive...

Biogen Idec, Inc. (Massachusetts) to Present at the Deutsche Bank 38th Annual dbAccess Healthcare Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Biogen Idec Inc. (NASDAQ: BIIB) announced today that it will present at the Deutsche Bank 38th Annual dbAccess Healthcare Conference. The webcast will be live on Thursday, May 30, 2013 at 12:00 p.m. ET. To access...

NPS Pharmaceuticals, Inc. to Present at Deutsche Bank Health Care Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the Deutsche Bank Securities 38th Annual Health Care Conference in Boston on Wednesday, May 29, 2013 at 8:00 a.m. ET. The presentation will be available...

Covidien and Mallinckrodt Inc. to Present at Deutsche Bank Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Deutsche Bank 38th Annual Health Care Conference in Boston on Wednesday and Thursday, May 29 and 30, 2013.
...

Intercept Pharmaceuticals to Present at Deutsche Bank Healthcare Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK, May 23, 2013 /PRNewswire/ -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) (Intercept), a clinical stage biopharmaceutical...

VIVUS, Inc. Announces Scientific Presentations

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MOUNTAIN VIEW, Calif., May 22, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity...

Celldex Therapeutics, Inc. to Present at Two Upcoming Investor Conferences

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEEDHAM, Mass., May 22, 2013 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that Anthony Marucci, President and Chief Executive Officer, will present a corporate overview at the...

Polish-Hungarian Cooperation Agreement Signed ??? Started

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Budapest, Hungary - 22nd May, 2013 -- About 10 oclock, during BioForum 2013 opening ceremony, with witnesses from Hungarian and Polish government, cooperation agreement between Polish Biotech Association...

Auxogyn, Inc. Selected to Present at in Stockholm

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Menlo Park, CA May 22 2013 Auxogyn, Inc., a company focused on revolutionizing the field of reproductive medicine by providing novel scientific and clinically validated solutions to IVF clinicians and their...

Valeant Pharmaceuticals International Announces 2013 Annual Meeting Results

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LAVAL, Quebec, May 21, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today...

Omeros Corporation to Present at Two Upcoming Conferences

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, May 22, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering...

Biotechnology Industry Organization (BIO) Issues Call for Paper and Panel Submissions for

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

The Biotechnology Industry Organization (BIO) invites leaders from the biotechnology, chemical and agricultural industries to submit proposals and abstracts for panels, individual papers and posters for the...

CEO of Immune Pharmaceuticals to Present at

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

Immune Pharmaceuticals Ltd. (Immune), a privately held Israeli company, and EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that Daniel Teper...

Alkermes plc Announces Data on ALKS 5461 and ALKS 3831 to be Presented at 53rd Annual Meeting

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Alkermes plc (NASDAQ: ALKS) today announced that clinical data on ALKS 5461, a novel drug candidate for major depressive disorder (MDD) in patients who have an inadequate response to standard therapies for clinical...

Incyte Corporation to Present at Upcoming Investor Conferences

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Incyte Corporation (Nasdaq:INCY) announced today it will present at the following investor conferences during the month

of June: Jefferies 2013 Global Healthcare Conference on Thursday, June 6...

Navidea Biopharmaceuticals Announces the Presentation of Lymphoseek?? Data at

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that data from its Lymphoseek (technetium Tc 99m tilmanocept...

AVANIR Pharmaceuticals to Participate in Two Upcoming Investor Conferences

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ALISO VIEJO, Calif., May 22, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced...

Pluristem Therapeutics Welcomes Parliamentary State Secretary of the German Federal Ministry for Environmental, Nature Conservation and Nuclear Safety and the

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HAIFA, Israel, May 22, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that Katherina Reiche, Parliamentary...

CEO of Immune Pharmaceuticals to Present at

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Immune Pharmaceuticals Ltd. (Immune), a privately held Israeli company, andEpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announcedtoday that Daniel Teper, Chief Executive Officer...

GeneNews to Present at the Healthcare Investor Conference

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TORONTO, May 21, 2013 (GLOBE NEWSWIRE) -- GeneNews Limited (TSX:GEN) ("GeneNews") announced today that its President and Chief Operating Officer, Gailina J. Liew, will present an update on the Company's business...

ImmunoCellular Therapeutics, Ltd to Present at MicroCap Conference on May 30th

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ImmunoCellular Therapeutics, Ltd. (ImmunoCellular) (NYSE MKT: IMUC) today announced that Andrew Gengos, Chief Executive Officer of ImmunoCellular, will present a corporate overview and business update at the...

Medifocus to Present tt the Second Annual MicroCap Conference

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

COLUMBIA, Md. and TORONTO, May 22, 2013 /PRNewswire/ -- Medifocus, Inc. (OTCQX: MDFZF...

Can-Fite BioPharma to Present at the Second Annual MicroCap Conference

Wed, 22 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PETACH TIKVA, Israel, May 22, 2013 /PRNewswire/ -- Can-Fite BioPharma (TASE: CFBI, OTC: CANFY), a biotechnology company...

Cleveland Biolabs Inc. to Present at Second Annual Microcap Conference

Wed, 22 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BUFFALO, N.Y., May 22, 2013 /PRNewswire/ -- Cleveland BioLabs, Inc. (NASDAQ:CBLI) today announced that the Company...

Regulus Therapeutics, Inc. to Present at Deutsche Bank 38th Annual Healthcare Conference

Wed, 22 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LA JOLLA, Calif., May 21, 2013 /PRNewswire/ -- Regulus Therapeutics...

Infinity Pharmaceuticals Inc. to Present at Deutsche Banks 38th Annual Health Care Conference

Wed, 22 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at Deutsche Bank's 38th Annual Health Care Conference on May 29, 2013, at 4:15 p.m. ET in Boston, MA.

A live webcast of Infinity...

Chelsea Therapeutics, Inc. to Present at the 38th Annual Deutsche Bank Health Care Conference

Wed, 22 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CHARLOTTE, N.C., May 22, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 38th Annual Deutsche Bank Health Care Conference at 4:50 PM on Wednesday...

Curis, Inc. to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference

Wed, 22 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LEXINGTON, Mass., May 22, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop next generation targeted drug candidates for cancer treatment, today announced that...

Abbott Laboratories to Present at Deutsche Bank 38th Annual Health Care Conference

Wed, 22 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ABBOTT PARK, Ill., May 22, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) will participate in the Deutsche Bank 38^th Annual Health Care...

ZIOPHARM Oncology, Inc. to Present at the 38th Annual Deutsche Bank Health Care Conference

Wed, 22 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOSTON, May 22, 2013 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that Jonathan Lewis, M.D., Ph.D., Chief Executive Officer, will present at the 38th Annual Deutsche Bank Health...

Generex Biotechnology Corporation Announces American Society of Clinical Oncology Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine

Wed, 22 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WORCESTER, Mass. and TORONTO, May 22, 2013 /PRNewswire/ -- Generex Biotechnology Corporation...

Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology

Wed, 22 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO, May 22, 2013 /PRNewswire/ -- Ambit Biosciences Corporation (Nasdaq: AMBI) today announced that data from clinical...

Clinical Data on TetraLogic Pharmaceuticals??? Smac Mimetic Birinapant to be Presented at American Society of Clinical Oncology

Wed, 22 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced that data from two clinical studies investigating its lead Smac mimetic...

OncoGenex Pharmaceuticals Inc. Announces Multiple 'Trials in Progress' Presentations at the 2013 American Society of Clinical Oncology Annual Meeting

Wed, 22 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOTHELL, Wash. and VANCOUVER, British Columbia, May 22, 2013 /PRNewswire/ -- OncoGenex...

Rosetta Genomics Ltd. to Present at the Jefferies and Co. 2013 Healthcare Conference

Wed, 22 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PHILADELPHIA and REHOVOT, Israel, May 22, 2013 /PRNewswire/ -- Rosetta Genomics Ltd...

Gentiva Health Services to Present at Upcoming Investor Conferences

Tue, 21 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ATLANTA, May 20, 2013 /PRNewswire/ -- Gentiva Health Services, Inc. (Nasdaq: GTIV) announced today that it will participate...

Valeant Pharmaceuticals International to Present at 34th Annual Goldman, Sachs & Co. Global Healthcare Conference

Tue, 21 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LAVAL, Quebec, May 20, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX...

Boehringer Ingelheim Corporation Presents Phase 3 Sub-Analyses for Tiotropium Across a Range of Symptomatic Asthma Patients at American Thoracic Society 2013

Tue, 21 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

RIDGEFIELD, Conn., May 21, 2013 /PRNewswire/ -- Boehringer Ingelheim today announced data from Phase 2 and Phase 3 studies...

Verastem, Inc. to Present at Upcoming Conferences

Tue, 21 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Verastem, Inc., (NASDAQ: VSTM) focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that members of the management team will be presenting at several...

Medidata Solutions, Inc. to Present at the 14th Annual Investor Conference

Tue, 21 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for the life sciences industry, today announced that Cory Douglas, chief financial officer, will present at the 14th Annual B. Riley...

Safeguard Scientifics Annual Meeting of Shareholders to be Held on Thursday, May 23 at 8:00 A.M. EDT

Tue, 21 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in growth-stage healthcare and technology companies, today announced that its annual meeting of shareholders will be held on Thursday...

AstraZeneca PLC Release: Results from Phase III Studies of Naloxegol for Treatment of Opioid-Induced Constipation Presented at

Tue, 21 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

AstraZeneca (NYSE: AZN) today presented the results of two pivotal Phase III studies of naloxegol showing the 25 mg dose of the investigational drug met its primary and secondary endpoints for efficacy and showed...

Elekta Nomination Committee???s Proposals for the 2013 Annual General Meeting

Tue, 21 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

The Nomination Committee of Elekta AB (publ) proposes that the 2013 Annual General Meeting elects Laurent Leksell as the new Chairman of the Board. Akbar Seddigh, who has been Chairman...

Prima Biomed to Present at the

Tue, 21 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SYDNEY, AUSTRALIA - Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD; ISIN: US74154B2034) (Prima, the Company) has announced today that Matthew Lehman, its Chief Executive Officer, will present at the Second Annual...

Zealand Pharma to Present at Upcoming Global Healthcare Investor Conferences in the U.S.

Tue, 21 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL) (Zealand), a Danish biotechnology company dedicated to the discovery and development of novel peptide drugs, informs it will present at the following upcoming...

Two in Three Cancer Patients Are Non-Adherent With Their Medications, According to Research

Tue, 21 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK, May 21, 2013Two-thirds of patients who have been diagnosed with leukemia, melanoma or non-small cell lung cancer reported that they engage in at least one type of non-adherent behavior in their medicine...

Proteostasis Therapeutics, Inc. Presents Preclinical Data on Parkinson???s Disease and Cystic Fibrosis Targets at Conference

Tue, 21 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with neurodegenerative and orphan...

Biotechnology Industry Organization (BIO) Issues Call for Paper and Panel Submissions for

Tue, 21 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) invites leaders from the biotechnology, chemical and agricultural industries to submit proposals and abstracts for panels, individual...

Cordis Corporation Showcases Cardiovascular Innovations at

Tue, 21 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Cordis Corporation, a global leader in innovative technology for cardiovascular interventions, will introduce the two latest additions to its portfolio of cardiovascular solutions at EuroPCR 2013, 21-24 May...

Synthetic Biologics, Inc. to Present at the 2nd Annual MicroCap Conference

Tue, 21 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ROCKVILLE, Md., May 21, 2013 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics...